The Medicine Maker / Power List / 2021

The Power List 2021

Welcome to our annual celebration of the great and inspirational minds that contribute to the development and manufacture of new medicinal products, including small molecules, biopharmaceuticals, and advanced therapies.

The 2021 Power List was put together based on reader nominations, and whittled down by an international panel of judges.

Small Molecules

Phil S. Baran

Professor at Scripps Research

Ross T. Burn

Chief Executive Officer at CatSci Ltd

Kelly Chibale

Neville Isdell Chair in African-Centric Drug Discovery & Development and South Africa Research Chair in Drug Discovery

John Chiminski

Chair and Chief Executive Officer at Catalent Pharma Solutions

Paolo Colombo

Emeritus Professor at the University of Parma

Athena Countouriotis

President and Chief Executive Officer at Turning Point Therapeutics

Will Downie

Chief Executive Officer at Vectura

Edward Haeggström

Chief Executive Officer at Nanoform

Alison Holmes

Professor of Infectious Diseases at Imperial College London

Johannes Khinast

Professor of Pharmaceutical Engineering at Graz University of Technology and CEO of RCPE

Nik Kotecha

Chairman of Morningside Pharmaceuticals Ltd

M. N. V. Ravi Kumar

Professor at the University of Alabama in Tuscaloosa

Robert S. Langer

David H. Koch Institute Professor at the Massachusetts Institute of Technology

Nigel Langley

Global Technology Director at BASF

Andrew Moore

General Manager at Pfizer CentreOne

Faith Osier

Group Leader, Malaria Vaccine Development at KEMRI – Wellcome, Kenya and Visiting Professor of Immunology at Oxford University

GV Prasad

Co-Chairman and Managing Director at Dr. Reddy’s Laboratories

John Talley

Chief Scientific Officer at Euclises Pharmaceuticals

Matthew Todd

Professor of Drug Discovery at University College London

Martin VanTrieste

President and Chief Executive Officer at Civica Rx

Biopharmaceuticals

Hal Baseman

Chief Operating Officer at Valsource

Rick Bright

Senior Vice President, Pandemic Prevention & Response, Health Initiative at the Rockefeller Foundation

Karen Flynn

President, Biologics & Chief Commercial Officer at Catalent

Kenneth C. Frazier

Chairman and Chief Executive Officer at Merck Sharp & Dohme

Justin Hanes

Lewis J. Ort Professor of Ophthalmology at John Hopkins University; and Director at the Center for Nanomedicine

Jackie Hunter

Board Director at BenevolentAI

Maik Jornitz

President and CEO at G-Con Manufacturing

Maria José Alonso

Professor at the University of Santiago de Compostela CIMUS Research Institute

Jean-Paul Kress

CEO at MorphoSys

Neil Kumar

Founder and CEO at BridgeBio Pharma

Emmanuel Ligner

President and CEO at Cytiva; Group Executive at Danaher Biotechnology Group

Kiran Mazumdar-Shaw

Executive Chairperson at Biocon and Biocon Biologics

Rino Rappuoli

Chief Scientist and Head of External R&D at GlaxoSmithKline

Mike Rea

Chief Executive Officer, Idea Pharma

Melinda Richter

Global Head of JLabs at Johnson & Johnson Innovation

Gil Roth

President at the Pharma & Biopharma Outsourcing Association

James N. Thomas

EVP, Global Head of Biotherapeutics and President of US Operations at Just - Evotec Biologics

Jan van de Winkel

President and CEO at Genmab

Mike Vandiver

Senior Vice President of Biotherapeutic Operations at Just - Evotec Biologics

Emma Walmsley

Chief Executive Officer at GlaxoSmithKline

Advanced Medicine

Usman “Oz” Azam

President and Chief Executive Officer at Tmunity Therapeutics

Catherine Bollard

Director at the Children’s National Research Institute; and Professor of Pediatrics at George Washington University

Vered Caplan

Chief Executive Officer at Orgenesis

Massimo Dominici

Professor at the University Hospital of Modena and Reggio Emilia; and Scientific Founder of Rigenerand

Jennifer Doudna

Li Ka Shing Chancellor’s Professor of Biomedical Science at University of California, Berkeley

Miguel Forte

Chief Executive Officer at Bone Therapeutics

Fabian Gerlinghaus

Co-Founder and Chief Executive Officer at Cellares

Rachel Haurwitz

President and Chief Executive Officer at Caribou Biosciences

Deng Hongkui

Changjiang Professor, the Boya Chair Professor, and Director of the Institute of Stem Cell Research at Peking University

Queenie Jang

Chief Executive Officer at ISCT

Carl H. June

Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania

Bruce Levine

Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania

Peter Marks

Director at the FDA Center for Biologics Evaluation and Research

Marc Martinell

Co-Founder & Chief Executive Officer at Minoryx

Benjamin L. Oakes

Co-founder, President, and Chief Executive Officer at Scribe Therapeutics

Amy Ronneberg

Chief Executive Officer at Be The Match

James Thomson

Investigator, Regenerative Biology at the Morgridge Institute for Research at the University of Wisconsin, Madison

Evelina Vågesjö

Co-Founder and Chief Executive Officer at Ilya Pharma

Shinya Yamanaka

Director and Professor at the Center for iPS Cell Research and Application (CiRA); and Representative Director of the CiRA Foundation

Claudia Zylberberg

Chief Executive Officer at Akron Biotech

False

Explore

Featured Topics

Issues

Techniques & Tools

Applications & Fields

News & Blogs

Community & Awards